These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15300194)
41. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. Yang X; Chu Y; Wang Y; Zhang R; Xiong S J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511 [TBL] [Abstract][Full Text] [Related]
42. Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors. Kumar A; Farace F; Gaudin C; Triebel F J Clin Invest; 1996 Mar; 97(5):1219-26. PubMed ID: 8636433 [TBL] [Abstract][Full Text] [Related]
44. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion. Sussman JJ; Parihar R; Winstead K; Finkelman FD Cancer Res; 2004 Dec; 64(24):9124-30. PubMed ID: 15604282 [TBL] [Abstract][Full Text] [Related]
45. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
46. Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody. Wang Z; Zhang T; Hu H; Zhang H; Yang Z; Cui L; He W Cancer Lett; 2008 Dec; 272(2):242-52. PubMed ID: 18782650 [TBL] [Abstract][Full Text] [Related]
50. T cells to a dominant epitope of GAD65 express a public CDR3 motif. Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112 [TBL] [Abstract][Full Text] [Related]
51. Stable clonal expansion of the T-cell receptor V beta 6, V beta 17 and V beta 19 T cells in a cGVHD case using genescan analysis. Li Y; Du X; Xu M; Zhang T; Yang L; Chen S Chin Med J (Engl); 2001 May; 114(5):489-92. PubMed ID: 11780410 [TBL] [Abstract][Full Text] [Related]
52. The role of TCR specificity and clonal competition during reconstruction of the peripheral T cell pool. Leitão C; Freitas AA; Garcia S J Immunol; 2009 May; 182(9):5232-9. PubMed ID: 19380769 [TBL] [Abstract][Full Text] [Related]
53. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA; Flye MW J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414 [TBL] [Abstract][Full Text] [Related]
54. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer]. Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639 [TBL] [Abstract][Full Text] [Related]
55. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Risitano AM; Kook H; Zeng W; Chen G; Young NS; Maciejewski JP Blood; 2002 Jul; 100(1):178-83. PubMed ID: 12070025 [TBL] [Abstract][Full Text] [Related]
56. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
57. Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells. Zheng G; Liu S; Wang P; Xu Y; Chen A Cancer Res; 2006 Jul; 66(13):6793-9. PubMed ID: 16818656 [TBL] [Abstract][Full Text] [Related]
58. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Thanarajasingam U; Sanz L; Diaz R; Qiao J; Sanchez-Perez L; Kottke T; Thompson J; Chester J; Vile RG Cancer Res; 2007 Jan; 67(1):300-8. PubMed ID: 17210711 [TBL] [Abstract][Full Text] [Related]
59. [Enhancing antitumor activity of tumor-draining lymph node cells by autologous dendritic cells]. Peng Z; Li R; Li L; Zhang L; Jin T Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):595-7. PubMed ID: 15367357 [TBL] [Abstract][Full Text] [Related]
60. Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes. Ammori J; Hamzeh K; Graor H; Kim J J Immunol Res; 2015; 2015():170852. PubMed ID: 26090481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]